Munafa Stock Market Course + Intraday & FNO calls 
Repros Therapeutics (RPRX) Technical (Analysis) Reports Repros Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Repros Therapeutics (RPRX)
Technical Analysis Report for NASDAQ stock RPRX Repros Therapeutics. Dated: 17 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology: Biological Products (No Diagnostic Substances) in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock RPRX Repros Therapeutics then click here. or read Experts views on Repros Therapeutics or Forecast & share price targets of Repros Therapeutics
Repros Therapeutics Opened at 58.81 and Closed at: 58.93, which is 0.78% of previous session's close. It moved within a range of 58.46 and 59.18
The session was a Bullish session with an average volume of 2062500, which is -4.61% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 3 days back on short term averages
Support for tomorrow is 58.7 and resistance for tomorrow is 59.42
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 58.53, 58.14 resistance for tomorrow's hourly charts is 59.25, 59.58
10 Day SMA for Repros Therapeutics (RPRX) is 60.13 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Repros Therapeutics (RPRX) is 60.9 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Repros Therapeutics (RPRX) is 59.31 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 56.61 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Repros Therapeutics is 50.18 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Repros Therapeutics is at 60.9 and 200 DMA is at 50.18, while 50 DMA and 100 DMA are at 59.31 and 56.61 respectively
Repros Therapeutics (RPRX) moving average of 20 SMA is at 60.9 and 20 EMA is at 60.02
| Date | Closing Price | 20 SMA | 20 EMA |
| 17 Thu Sep | 58.93 | 60.9 | 60.02 |
| 16 Wed Sep | 58.47 | 61.04 | 60.14 |
| 15 Tue Sep | 58.47 | 61.1 | 60.32 |
| 14 Mon Sep | 59.05 | 61.15 | 60.52 |
| 11 Fri Sep | 58.61 | 61.13 | 60.67 |
| 10 Thu Sep | 58.75 | 61.13 | 60.89 |
Repros Therapeutics (RPRX) moving average of 50 SMA is at 59.31 and 50 EMA is at 59.06
| Date | Closing Price | 50 SMA | 50 EMA |
| 17 Thu Sep | 58.93 | 59.31 | 59.06 |
| 16 Wed Sep | 58.47 | 59.29 | 59.07 |
| 15 Tue Sep | 58.47 | 59.29 | 59.09 |
| 14 Mon Sep | 59.05 | 59.27 | 59.12 |
| 11 Fri Sep | 58.61 | 59.23 | 59.12 |
| 10 Thu Sep | 58.75 | 59.21 | 59.14 |
Repros Therapeutics (RPRX) moving average of 100 SMA is at 56.61 and 100 EMA is at 56.36
| Date | Closing Price | 100 SMA | 100 EMA |
| 17 Thu Sep | 58.93 | 56.61 | 56.36 |
| 16 Wed Sep | 58.47 | 56.52 | 56.31 |
| 15 Tue Sep | 58.47 | 56.43 | 56.27 |
| 14 Mon Sep | 59.05 | 56.34 | 56.23 |
| 11 Fri Sep | 58.61 | 56.25 | 56.17 |
| 10 Thu Sep | 58.75 | 56.16 | 56.12 |
Repros Therapeutics (RPRX) moving average of 200 SMA is at 50.18 and 200 EMA is at 51.51
| Date | Closing Price | 200 SMA | 200 EMA |
| 17 Thu Sep | 58.93 | 50.18 | 51.51 |
| 16 Wed Sep | 58.47 | 50.08 | 51.44 |
| 15 Tue Sep | 58.47 | 49.99 | 51.37 |
| 14 Mon Sep | 59.05 | 49.89 | 51.3 |
| 11 Fri Sep | 58.61 | 49.8 | 51.22 |
| 10 Thu Sep | 58.75 | 49.7 | 51.15 |
Repros Therapeutics has performed better than Xenon Pharmaceuticals in short term. Holding Repros Therapeutics could be a better choice for now!
Twist Bioscience has performed better than Repros Therapeutics in short term. You could have earned much better returns by investing in Twist Bioscience, about 16.83% more returns!
Tenax Therapeutics has performed better than Repros Therapeutics in short term. You could have earned much better returns by investing in Tenax Therapeutics, about 6.63% more returns!
Repros Therapeutics has performed better than Supernus Pharmaceuticals in short term. Holding Repros Therapeutics could be a better choice for now!
Repros Therapeutics has performed better than Sellas Life in short term. Holding Repros Therapeutics could be a better choice for now!
Puma Biotechnology has performed better than Repros Therapeutics in short term. You could have earned much better returns by investing in Puma Biotechnology, about 6.99% more returns!
Repros Therapeutics has performed better than Nature S in short term. Holding Repros Therapeutics could be a better choice for now!
Agios Pharmaceuticals has performed better than Repros Therapeutics in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 2.66% more returns!
Aurinia Pharmaceuticals has performed better than Repros Therapeutics in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 0.92% more returns!
Biolife Solutions has performed better than Repros Therapeutics in short term. You could have earned much better returns by investing in Biolife Solutions, about 2.4% more returns!
Repros Therapeutics has performed better than Cellectar Biosciences in short term. Holding Repros Therapeutics could be a better choice for now!
Repros Therapeutics has performed better than Collegium Pharmaceutical in short term. Holding Repros Therapeutics could be a better choice for now!
Repros Therapeutics has performed better than Equillium Inc in short term. Holding Repros Therapeutics could be a better choice for now!
Fulgent Genetics has performed better than Repros Therapeutics in short term. You could have earned much better returns by investing in Fulgent Genetics, about 12.41% more returns!
Halozyme Therapeutics has performed better than Repros Therapeutics in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 6.07% more returns!
Repros Therapeutics has performed better than Henry Schein in short term. Holding Repros Therapeutics could be a better choice for now!
Kura Oncology has performed better than Repros Therapeutics in short term. You could have earned much better returns by investing in Kura Oncology, about 2.81% more returns!
Repros Therapeutics has performed better than Mustang Bio in short term. Holding Repros Therapeutics could be a better choice for now!
Repros Therapeutics Technical analysis of indicators
Price action analysis of Repros Therapeutics (RPRX) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Repros Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Repros Therapeutics in short term but the sell signal is initial and weak.
Repros Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Repros Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Repros Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 60.33 and Repros Therapeutics RPRX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Repros Therapeutics RPRX stock. Volume based technical analysis of Repros Therapeutics RPRX stock is negative.
Repros Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock RPRX Repros Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And RPRX Experts View which covers a lot of information including buying and selling signals
RPRX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Repros Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Repros Therapeutics (RPRX) Technical (Analysis) Reports Repros Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
